NASDAQ:VKTX

Viking Therapeutics Stock Predictions

etoro logo Buy VKTX
*Your capital is at risk
$29.33
+0.0400 (+0.137%)
At Close: Jun 03, 2026
Currently predicting for Fri, 5 Jun 2026

VKTX Prediction Chart

VKTX Predictions History

Latest community submissions for VKTX.
Predictor Target Session Target Price Result Direction Accuracy Score
May 6, 2019 $8.56 -3.93% $8.91 X 96.07% 0
May 2, 2019 $7.96 -2.33% $8.15 X 97.67% 0
Apr 29, 2019 $8.59 +4.63% $8.21 X 95.37% 0
Apr 22, 2019 $9.20 +5.50% $8.72 X 94.50% 0
JS JS Pro
Apr 16, 2019 $8.78 -3.94% $9.14 X 96.06% 0
Apr 16, 2019 $8.97 -1.86% $9.14 X 98.14% 0
Apr 16, 2019 $9.15 +0.11% $9.14 X 99.89% 5
JS JS Pro
Apr 15, 2019 $8.97 +1.47% $8.84 X 98.53% 1
Apr 15, 2019 $9.52 +7.69% $8.84 X 92.31% 0
JS JS Pro
Apr 8, 2019 $10.50 -0.85% $10.59 X 99.15% 2
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for VKTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT VIKING THERAPEUTICS
Viking Therapeutics
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also dev...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE